- Home
- LQDT vs CVAC Comparison
LQDT vs CVAC Comparison
Compare LQDT & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- CVAC
- Stock Information
- Founded
- LQDT 1999
- CVAC 2000
- Country
- LQDT United States
- CVAC Germany
- Employees
- LQDT N/A
- CVAC N/A
- Industry
- LQDT Catalog/Specialty Distribution
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- LQDT Consumer Discretionary
- CVAC Health Care
- Exchange
- LQDT Nasdaq
- CVAC Nasdaq
- Market Cap
- LQDT 678.4M
- CVAC 637.1M
- IPO Year
- LQDT 2006
- CVAC 2020
- Fundamental
- Price
- LQDT $24.90
- CVAC $2.54
- Analyst Decision
- LQDT Buy
- CVAC Hold
- Analyst Count
- LQDT 1
- CVAC 3
- Target Price
- LQDT $27.00
- CVAC $10.00
- AVG Volume (30 Days)
- LQDT 115.2K
- CVAC 540.3K
- Earning Date
- LQDT 12-12-2024
- CVAC 11-12-2024
- Dividend Yield
- LQDT N/A
- CVAC N/A
- EPS Growth
- LQDT N/A
- CVAC N/A
- EPS
- LQDT 0.62
- CVAC N/A
- Revenue
- LQDT $336,348,000.00
- CVAC $70,565,734.00
- Revenue This Year
- LQDT $13.35
- CVAC $123.97
- Revenue Next Year
- LQDT $6.94
- CVAC N/A
- P/E Ratio
- LQDT $40.13
- CVAC N/A
- Revenue Growth
- LQDT 8.60
- CVAC 75.11
- 52 Week Low
- LQDT $13.99
- CVAC $2.22
- 52 Week High
- LQDT $25.79
- CVAC $6.30
- Technical
- Relative Strength Index (RSI)
- LQDT 70.07
- CVAC 34.97
- Support Level
- LQDT $21.34
- CVAC $2.73
- Resistance Level
- LQDT $25.79
- CVAC $2.97
- Average True Range (ATR)
- LQDT 0.51
- CVAC 0.18
- MACD
- LQDT 0.30
- CVAC -0.01
- Stochastic Oscillator
- LQDT 80.00
- CVAC 7.55
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.